Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
77.8
Year-on-year change in operating income (%)Wording
Avoiding a definitive answer
How definitive the wording is.Results for this period
Full year1 January 2025 to 31 December 2025ConsolidatedJapanese GAAPNet Sales49,518¥ millionYear on year -7.0%
Operating profit15,866¥ millionYear on year +77.8%
Ordinary income15,257¥ millionYear on year +80.9%
Net income attributable to owners of the parent10,448¥ millionYear on year +120.2%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
Net income per share88.55円
Operating Margin32.0％
Financial position at period-end
Total assets1,406,809¥ million
of which net assets 53,017 ¥ millionEquity ratio 3.8%vs. prior year-end +0.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+11,896
Investment+723
Financials+10,410
Net change+23,029
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥138,821 million
Segment revenue
Securities and FX business40,12585.8%-8.4%
Cryptocurrency Business6,66614.2%-11.2%
Segment profit
Securities and FX business13,42080.5%+152.7%
Cryptocurrency Business3,24619.5%-18.1%
Outlook and shareholder returns
Annual Dividend Forecast¥57.58 → ¥42.08（-26.9%）
Payout ratio65.0％
Shareholder Return Policy配当性向65％以上、DOE（連結株主資本配当率）10％を下限指標
Factors Behind Changes in Business Performance
前期にタイ王国の証券事業等に係る貸倒引当金繰入額9,534百万円を計上していた反動により利益が増加。証券・FX事業は外国為替市場のボラティリティ低下とレンジ相場による収益性低下で減収、暗号資産事業は第4四半期のレンジ相場による収益性低下で減収。
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Availableそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 2 / Company name GMOヘルスケア株式会社, ハヤレジ株式会社
Material subsequent events2026年2月4日開催の取締役会で、執行役・従業員等を対象とする第3回新株予約権30,000個の発行を決議。全て行使された場合、約2.5％の希薄化が生じる見込み。
Impairment loss¥0 million
Breakdown of extraordinary income (loss)Extraordinary income Reversal of the reserve for financial instruments transaction liability ¥9 million, Other ¥0 million / Extraordinary loss 顧客損失補填金 ¥150 million, Impairment Loss on Investment Securities ¥68 million, Loss on disposal of non-current assets ¥36 million, Impairment losses ¥0 million
Depreciation and amortization¥1,993 million
Availability of Supplementary Financial Results MaterialsAvailable
Availability of Financial Results Briefing有（アナリスト・機関投資家向け、ライブ配信のみ）
Issued Shares at Period-End122,091,903
Treasury Shares at Period-End4,102,585
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2025 to 31 December 2025 |
| Net Sales | ¥49,518 million (YoY -7.0%) |
| Operating profit | ¥15,866 million (YoY +77.8%) |
| Ordinary income | ¥15,257 million (YoY +80.9%) |
| Profit attributable to owners of the parent | ¥10,448 million (YoY +120.2%) |
| Net income per share | 88.55円 |
| Operating Margin | 32.0％ |
| Equity ratio | End of the current fiscal period 3.8 / End of previous period 3.4 |
| Total assets | ¥1,406,809 million |
| Net assets | ¥53,017 million |
| Cash flows from operating activities | ¥11,896 million |
| Cash flows from investing activities | ¥723 million |
| Cash flows from financing activities | ¥10,410 million |
| Cash and cash equivalents at end of period | ¥138,821 million |
| Annual Dividend Forecast | ¥57.58 → ¥42.08（-26.9%） |
| Payout ratio | 65.0％ |
| Shareholder Return Policy | 配当性向65％以上、DOE（連結株主資本配当率）10％を下限指標 |
| Segment revenue | Securities and FX business ¥40,125 million (YoY -8.4%) / Cryptocurrency Business ¥6,666 million (YoY -11.2%) |
| Segment profit | Securities and FX business ¥13,420 million (YoY +152.7%) / Cryptocurrency Business ¥3,246 million (YoY -18.1%) |
| Depreciation and amortization | ¥1,993 million |
| Impairment loss | ¥0 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Reversal of the reserve for financial instruments transaction liability ¥9 million, Other ¥0 million / Extraordinary loss 顧客損失補填金 ¥150 million, Impairment Loss on Investment Securities ¥68 million, Loss on disposal of non-current assets ¥36 million, Impairment losses ¥0 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards Available / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 2 / Company name GMOヘルスケア株式会社, ハヤレジ株式会社 |
| Material subsequent events | 2026年2月4日開催の取締役会で、執行役・従業員等を対象とする第3回新株予約権30,000個の発行を決議。全て行使された場合、約2.5％の希薄化が生じる見込み。 |
| Availability of Supplementary Financial Results Materials | Available |
| Availability of Financial Results Briefing | 有（アナリスト・機関投資家向け、ライブ配信のみ） |
| Issued Shares at Period-End | 122,091,903 |
| Treasury Shares at Period-End | 4,102,585 |
| Factors Behind Changes in Business Performance | 前期にタイ王国の証券事業等に係る貸倒引当金繰入額9,534百万円を計上していた反動により利益が増加。証券・FX事業は外国為替市場のボラティリティ低下とレンジ相場による収益性低下で減収、暗号資産事業は第4四半期のレンジ相場による収益性低下で減収。 |
Items this document does not state (4)
Full-year earnings forecastRevision to Earnings ForecastRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.前連結会計年度にタイ王国の証券事業等に係る貸倒引当金繰入額9,534百万円を販売費及び一般管理費に計上していたことの反動。証券・FX事業では外国為替市場のボラティリティ低下やレンジ相場による収益性低下、暗号資産事業では第4四半期のレンジ相場による収益性低下が減収要因となった。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.